Stratification for early (stage I or II) versus late (stage III or IV) tumor stages revealed that MKK3 is preferentially and significantly highly expressed in late stage disease (p = 0.043) (Fig. 1b and Supplementary Table 1). The gene discussed is MAP2K3; the disease is neoplasm.